Published guidance, NICE advice and quality standards | Guidance

Showing 401 to 410 of 2557

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Lutetium-177 vipivotide tetraxetan for treating PSMA-positive hormone-relapsed metastatic prostate cancer after 2 or more treatments	TA930	15 November 2023	15 November 2023
Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer	CG164	25 June 2013	14 November 2023
Cabozantinib for previously treated advanced differentiated thyroid cancer unsuitable for or refractory to radioactive iodine	TA928	1 November 2023	1 November 2023
Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction	TA929	1 November 2023	1 November 2023
Acute respiratory infection in over 16s: initial assessment and management including virtual wards (hospital at home)	QS210	31 October 2023	31 October 2023
Jaundice in newborn babies under 28 days	CG98	19 May 2010	31 October 2023
Ranibizumab for treating diabetic macular oedema	TA274	27 February 2013	26 October 2023
Vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions	HTG699	25 October 2023	25 October 2023
Daratumumab with lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable	TA917	25 October 2023	25 October 2023
Mirikizumab for treating moderately to severely active ulcerative colitis	TA925	25 October 2023	25 October 2023